BioBusinessBlog

Israeli Biotech to Facilitate Early Detection of HIV and HCV

January 3, 2008 · 2 Comments

Israel based Smart Biotech has developped a new blood sample treatment technique, SMARTube which enhances antibody production and allows to detect the HIV virus within 2-3 days of infection. This is a major advance in the fight against HIV since currenty tests can remain negative for weeks or even months in infected individuals. The SMARTube technique is also being developed for the early detection of Hepatitis C ( HCV).

Watch an interview of Dr Tamar Jehuda from Smart Biotech. This video has been produced by Israel High Tech TV.

Categories: Ventures
Tagged: , , , , , ,

2 responses so far ↓

  • surgeon12345 // January 22, 2008 at 4:17 am |

    I have watched the video – impressive. Unfortunately we are living in a society where all must be proven. I have searched the web for scientific publications – couldn’t find any. Where can I find peer – reviewed scientific publications on this product??

  • person7 // March 28, 2008 at 4:50 pm |

    I have heard a presentation by the invetor which included much clinical results from different countries. Very impresive solid data, including official reports by independent researchers and official health authorities. I hope to see this implemented in my country. it sure could use it!

You must be logged in to post a comment.